Despite attempts by the Ministry of Health in Germany to reassure German citizens, the Robert Koch Institute's vaccination committee has chosen not to recommend AstraZeneca's anti-Covid vaccine to people aged 65 and over. Researchers are therefore opting for preventive proscription, faced with the lack of tenable scientific data on the risks or safety of injections in the elderly. AstraZeneca's vaccine is awaiting authorization by the European Medicines Agency. In this context, the German commission advised to use it only in individuals between 18 and 64 years old, according to Les Echos. In the project, it is also recommended to space the two injections 9 to 12 weeks apart. The conclusions could be made public on Friday, after the opinion of the European Agency on the authorization or not of the vaccine. But the showdown is already underway. Earlier this week, German government sources suggested that the double-injection would be effective only on 8% of the +65 population, which the British lab refuted, citing a misinterpretation. The next day, the German Ministry of Health denied the data relayed by the German press. Germany is not the only country to have ordered vaccine doses from AstraZeneca, in its response to the pandemic of the new coronavirus. The question of effectiveness for senior individuals could arise in several countries. The questions remain unanswered, while Morocco officially launched its national campaign on Thursday, after the first deliveries of AstraZeneca and Sinopharm were received. In Morocco, senior people are the first to be vaccinated. Bilan Coronavirus dans le monde 259 465 151 Contaminations 5 174 661 Décès 235 366 205 Guérisons 53.8% de la population mondiale vaccinée
